These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12519734)

  • 41. Detection of a small lung cancer hidden in pneumoconiosis with progressive massive fibrosis using F-18 fluorodeoxyglucose PET/CT.
    Je SK; Ahn MI; Park YH; Kim CH
    Clin Nucl Med; 2007 Mar; 32(3):247-8. PubMed ID: 17314613
    [No Abstract]   [Full Text] [Related]  

  • 42. [Diagnostic value of positron emission tomography (PET) in clinical oncology].
    Czech N; Brenner W; Kampen WU; Henze E
    Dtsch Med Wochenschr; 2000 May; 125(18):565-7. PubMed ID: 10835983
    [No Abstract]   [Full Text] [Related]  

  • 43. Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.
    Präuer HW; Weber WA; Römer W; Treumann T; Ziegler SI; Schwaiger M
    Br J Surg; 1998 Nov; 85(11):1506-11. PubMed ID: 9823912
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Combined functional and morphological imaging with PET/CT systems].
    Kaim AH; von Schulthess GK
    Praxis (Bern 1994); 2003 Feb; 92(6):225-7. PubMed ID: 12645384
    [No Abstract]   [Full Text] [Related]  

  • 45. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease.
    Farrell MA; McAdams HP; Herndon JE; Patz EF
    Radiology; 2000 Jun; 215(3):886-90. PubMed ID: 10831716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Positron emission tomography in oncology].
    Hatazawa J; Higuchi I; Nakamura H
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):748-54. PubMed ID: 12852339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamic threshold for radiation target volume by PET/CT.
    Wong CY; Mahajan P; Yan D
    J Nucl Med; 2007 May; 48(5):849; author reply 847. PubMed ID: 17475975
    [No Abstract]   [Full Text] [Related]  

  • 48. Guest editorial: the conception of FDG-PET imaging.
    Alavi A; Reivich M
    Semin Nucl Med; 2002 Jan; 32(1):2-5. PubMed ID: 11839067
    [No Abstract]   [Full Text] [Related]  

  • 49. Simultaneous demonstration of metabolic lesions consistent with Alzheimer disease and brain metastases on FDG-PET imaging.
    Takalkar AM; El-Haddad G; Lilien DL; Patterson JC
    Clin Nucl Med; 2008 Jun; 33(6):438-40. PubMed ID: 18496460
    [No Abstract]   [Full Text] [Related]  

  • 50. In regard to Paulino and Johnstone: Use of PET and CT imaging data in radiation therapy planning. Int J Radit Oncol Biol Phys 2004;59:4-5.
    MacManus M; Hicks R; Bayne M; Leong T; Peters L; Ball D
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):1005-6; author reply 1006. PubMed ID: 15465222
    [No Abstract]   [Full Text] [Related]  

  • 51. PET versus PET/CT dual-modality imaging in evaluation of lung cancer.
    Freudenberg LS; Rosenbaum SJ; Beyer T; Bockisch A; Antoch G
    Radiol Clin North Am; 2007 Jul; 45(4):639-44, v. PubMed ID: 17706528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Positron emission and computed X-ray tomography: a coming together.
    Costa DC; Visvikis D; Crosdale I; Pigden I; Townsend C; Bomanji J; Prvulovich E; Lonn A; Ell PJ
    Nucl Med Commun; 2003 Apr; 24(4):351-8. PubMed ID: 12673162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiation-induced esophagitis on FDG PET imaging.
    Bhargava P; Reich P; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Oct; 28(10):849-50. PubMed ID: 14508282
    [No Abstract]   [Full Text] [Related]  

  • 54. Correlation of positron emission tomography and CT in evaluating pancreatic tumors: technical and clinical implications.
    Kalra MK; Maher MM; Boland GW; Saini S; Fischman AJ
    AJR Am J Roentgenol; 2003 Aug; 181(2):387-93. PubMed ID: 12876016
    [No Abstract]   [Full Text] [Related]  

  • 55. PET-CT-guided percutaneous puncture of an infected cyst in autosomal dominant polycystic kidney disease: case report.
    Kaim AH; Burger C; Ganter CC; Goerres GW; Kamel E; Weishaupt D; Dizendorf E; Schaffner A; von Schulthess GK
    Radiology; 2001 Dec; 221(3):818-21. PubMed ID: 11719684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Positron-emission tomography in oncology].
    Carreras Delgado JL
    An R Acad Nac Med (Madr); 1997; 114(2):445-70; discussion 470-8. PubMed ID: 9412252
    [No Abstract]   [Full Text] [Related]  

  • 57. Intense fluorodeoxyglucose activity in pulmonary amyloid lesions on positron emission tomography.
    Kung J; Zhuang H; Yu JQ; Duarte PS; Alavi A
    Clin Nucl Med; 2003 Dec; 28(12):975-6. PubMed ID: 14663319
    [No Abstract]   [Full Text] [Related]  

  • 58. F-18 FDG brain positron emission tomography and Tl-201 early and delayed SPECT in distinguishing atypical cerebral tumor from cerebral infarction.
    Liu HG; Mountz JM
    Clin Nucl Med; 2003 Mar; 28(3):241-2. PubMed ID: 12592141
    [No Abstract]   [Full Text] [Related]  

  • 59. Hydropneumothorax on FDG PET imaging.
    Ollenberger GP; Poon AM
    Clin Nucl Med; 2004 Apr; 29(4):277-8. PubMed ID: 15096982
    [No Abstract]   [Full Text] [Related]  

  • 60. Molecular (functional) imaging for radiotherapy applications: an RTOG symposium.
    Chapman JD; Bradley JD; Eary JF; Haubner R; Larson SM; Michalski JM; Okunieff PG; Strauss HW; Ung YC; Welch MJ
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):294-301. PubMed ID: 12527041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.